World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
140
Citations
123017
World Ranking
1650
National Ranking
164

Overview

Perry M. Elliott is affiliated with University College London in the United Kingdom. Their research primarily focuses on cardiology and cardiovascular medicine, with significant contributions to molecular biology as well. Their work encompasses a broad area of study within medicine and related fields.

Their research covers key topics such as:

  • Cardiomyopathy and Myosin Studies
  • Cardiovascular Effects of Exercise
  • Cardiovascular Function and Risk Factors
  • Viral Infections and Immunology Research
  • Cardiac Pacing and Defibrillation Studies
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Congenital Heart Defects Research

Perry M. Elliott's subfields of study include:

  • Cardiology and Cardiovascular Medicine
  • Molecular Biology
  • Epidemiology
  • Genetics
  • Surgery

Their frequent co-authors include:

  • Roberto Barriales-Villa
  • Petros Syrris
  • Pablo García-Pavía
  • Iacopo Olivotto
  • Luís R. Lopes

They publish regularly in several venues, including:

  • European Heart Journal
  • Journal of the American College of Cardiology
  • Circulation
  • JACC Heart Failure
  • European Journal of Heart Failure

Among their recent published papers are:

  • 2023 ESC Guidelines for the management of cardiomyopathies, 2023, European Heart Journal
  • 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease, 2020, European Heart Journal
  • Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial, 2020, The Lancet
  • European Society of Cardiology: cardiovascular disease statistics 2021, 2021, European Heart Journal
  • 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary, 2020, Journal of the American College of Cardiology

Best Publications

  • 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

    Piotr Ponikowski;Adriaan A. Voors;Stefan D. Anker;Héctor Bueno

  • ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

    John J.V. McMurray;Stamatis Adamopoulos;Stefan D. Anker;Angelo Auricchio

  • ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).

    Kenneth Dickstein;Alain Cohen-Solal;Gerasimos Filippatos;John J V McMurray

  • 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)

    Perry M Elliott;Aris Anastasakis

  • 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy : The Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA)

    Michele Brignole;Angelo Auricchio;Gonzalo Baron-Esquivias;Pierre Bordachar

  • ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008

    John Camm;Veronica Dean;Jose Luis Zamorano;Perry M. Elliott

  • Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases

    Perry Elliott;Bert Andersson;Eloisa Arbustini;Zofia Bilinska

  • Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.

    Alida L. P. Caforio;Sabine Pankuweit;Eloisa Arbustini;Cristina Basso

  • 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy

    Perry M. Elliott;Aris Anastasakis;Michael A. Borger;Martin Borggrefe

  • 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC).

    Silvia G. Priori;Carina Blomström-Lundqvist

  • Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy

    Mathew S. Maurer;Jeffrey H. Schwartz;Balarama Gundapaneni;Perry M. Elliott

  • 2018 ESC Guidelines for the diagnosis and management of syncope.

    Michele Brignole;Angel Moya;Frederik J de Lange;Jean-Claude Deharo

  • 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapyDeveloped by the Task Force on cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology (ESC) With the special contribution of the European Heart Rhythm Association (EHRA)

    Michael Glikson;Jens Cosedis Nielsen;Mads Brix Kronborg;Yoav Michowitz

  • Sudden death in hypertrophic cardiomyopathy: identification of high risk patients.

    Perry M Elliott;Jan Poloniecki;Shaughan Dickie;Sanjay Sharma

  • A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD)

    Constantinos O'Mahony;Fatima Jichi;Menelaos Pavlou;Lorenzo Monserrat

  • 2018 ESC Guidelines for the diagnosis and management of syncope

    Michele Brignole;Angel Moya;Frederik J. de Lange;Jean-Claude Deharo

  • Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice : a position statement of the ESC working group on myocardial and pericardial diseases

    Yigal M Pinto;Perry M Elliott;Eloisa Arbustini;Yehuda Adler

  • Equilibrium Contrast Cardiovascular Magnetic Resonance for the Measurement of Diffuse Myocardial Fibrosis Preliminary Validation in Humans

    Andrew S. Flett;Martin P. Hayward;Michael T. Ashworth;Michael S. Hansen

  • Toward clinical risk assessment inhypertrophic cardiomyopathy withgadolinium cardiovascular magnetic resonance

    James C.C Moon;William J McKenna;Jane A McCrohon;Perry M Elliott

  • 2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.

    Silvia G. Priori;Carina Blomström-Lundqvist;Andrea Mazzanti;Nico Blom

Frequent Co-Authors

William J. McKenna
William J. McKenna University College London
James C. Moon
James C. Moon University College London
Sanjay Sharma
Sanjay Sharma St George's, University of London
Derralynn Hughes
Derralynn Hughes Royal Free London NHS Foundation Trust
Luigi Tavazzi
Luigi Tavazzi University of Ferrara
Eloisa Arbustini
Eloisa Arbustini Policlinico San Matteo Fondazione
Claudio Rapezzi
Claudio Rapezzi University of Ferrara
Michael P. Frenneaux
Michael P. Frenneaux University of East Anglia
Aleš Linhart
Aleš Linhart Charles University
Dudley J. Pennell
Dudley J. Pennell National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in Medicine opens doors to a wide variety of online degrees and alternative pathways in healthcare. Many students choose to start with foundational programs such as an online bachelor's in nutrition, which provides a strong background in health sciences and can lead to unique specializations.

For those interested in healthcare administration, enrolling in top online mha programs that are cahme accredited offers the credibility and flexibility needed to advance into leadership positions. Nurses looking to further their education often consider accredited rn to bsn programs that do not require clinical hours, making it easier for working professionals to upskill.

For advanced practice, the demand for nurse leaders is growing. The fastest dnp online program options help experienced nurses gain doctoral-level expertise efficiently. These online programs are ideal for those balancing work, study, and personal commitments, enabling diverse career progressions in healthcare beyond traditional medical degrees.

Best Scientists Citing Perry M. Elliott

Trending Scientists